<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO> AP880307-0270 </DOCNO><FILEID>AP-NR-03-07-88 2002EST</FILEID><FIRST>r f BC-Earns-Robins     03-07 0240</FIRST><SECOND>BC-Earns-Robins,0251</SECOND><HEAD>A.H. Robins Reports Net Loss Despite Record Sales</HEAD><DATELINE>RICHMOND, Va. (AP) </DATELINE><TEXT>   Although sales for the A.H. Robins Co.jumped 11 percent for the final three months of 1987, thepharmaceutical company reported a net loss of $1.69 billion for theperiod because of costs related to its Dalkon Shield birth-controldevice.   Robins said its loss in the period compared to a profit of $26.2million, or $1.08 a share, in the same period a year earlier.Revenue rose to $234.8 million from $210.8 million a year earlier.   For all of 1987, Robins suffered a loss of $1.63 billioncompared to a profit of $81.8 million, or $3.38 a share, in 1986.Revenue for the year rose to $855.8 million from $789.9 million.   Robins was forced to set aside $1.75 billion last year to helpcover the costs of claims concerning women who were injured by theDalkon Shield, which has been discontinued.   The accrual represents the difference between the $2.30 billionprovided in the company's fifth amended reorganization plan and the$548 million which remained from the reserve for Dalkon Shieldclaims established by the company in 1984.   Robins' results were also hurt by the costs of its Chapter 11reorganization in federal bankruptcy court.   E. Claiborne Robins Jr., the president and chief executive, saidconsumer products in the U.S., international operations and medicalinstruments were the principal contributors to the higher sales forthe year.</TEXT></DOC>